Medicines are an important part of household health spending. A progressive system for financing drugs is thus essential for an equitable health system. Some authors have proposed that the determinants of equity in drug financing are socioeconomic, demographic, and associated with public interventions, but little progress has been made in the empirical evaluation and quantification of their relative importance. The current study estimated quantile regressions at the provincial level in Argentina and found that old age (> 65 years), unemployment, the existence of a public pharmaceutical laboratory, treatment transfers, and a health system orientated to primary care were important predictors of progressive payment schemes. Low income, weak institutions, and insufficient infrastructure and services were associated with the most regressive social responses to health needs, thereby aggravating living conditions and limiting development opportunities.
CITATION STYLE
Dondo, M., Monsalvo, M., & Garibaldi, L. A. (2016). Determinantes da equidade no financiamento de medicamentos na Argentina: Um estudo empírico. Cadernos de Saude Publica, 32(1). https://doi.org/10.1590/0102-311X00012215
Mendeley helps you to discover research relevant for your work.